Research
Energy balance
The high pricing of semaglutide (₹17,000–26,000/month) threatens equitable access.
Practitioners should be aware of the cost barriers that may limit patient access to semaglutide.
LimitedQualifiesmedium confidence
However, high pricing (₹17,000–26,000/month) threatens equitable access.
Why this rating
This is an opinion based on the abstract's discussion of pricing.
Source
Injectable Semaglutide (Wegovy) in India: Promise, Pitfalls and the Way Forward
Mehul Kaliya et al. · NMO journal · 2025
DOI 10.4103/jnmo.jnmo_55_25
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →